OnKure Therapeutics OKUR
NASDAQ OKUR
$2.58 +0.28 (+12.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Non Operating Interest Expenses (2024 - 2025)

Updated

OnKure Therapeutics (OKUR) reported Non Operating Interest Expenses of $6,000 for Q4 2025, down 89.5% from $57,000 a year earlier but up 200.0% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends

For FY2025, OnKure Therapeutics posted Non Operating Interest Expenses of $8,000, down 97.3% from FY2024.

  • By year, Non Operating Interest Expenses came in at $300,000 in FY2024.
  • Five-year quarterly Non Operating Interest Expenses spans a low of $2,000 in Q3 2025 and a high of $218,000 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 OnKure Therapeutics 104.48 Mn -393.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6,000.00
Sep 30, 2025 2,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 218,000.00
Jun 30, 2024 26,000.00
API Access

OnKure Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OKUR&period=max&api_key=YOUR_API_KEY